Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 4Phase 3 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 167fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 125Capecitabine 124Temozolomide 123Radiosurgery 118Biopsy 117Docetaxel 116Dexamethasone 113Ipilimumab 112Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Biopsy, Large-Core Needle × Clear all
NCT04024878 2025-06-18

NeoVax With Nivolumab in Patients With Ovarian Cancer

Dana-Farber Cancer Institute

Phase 1 Active not recruiting
22 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡